MHRA authorizes COVID-19 vaccines: Comirnaty and Nuvaxovid gain approvals

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a change to the license of the Comirnaty Omicron XBB.1.5 30 micrograms/dose (single-dose vials) after it was found to meet the UK regulator’s standards of safety, quality and effectiveness.

New therapeutic target could boost CAR T-cell therapy success in solid tumors

Russell W. Jenkins, MD, PhD, a physician investigator in the Krantz Family Center for Cancer Research at the Mass General Cancer Center and an assistant

January 10, 2025

4D Molecular Therapeutics’ gene therapy cuts Eylea use in wet AMD patients, biotech divulges plans for pivotal studies

4D Molecular Therapeutics said people with wet age-related macular degeneration (AMD) who received the company’s gene therapy as part of a clinical trial needed fewer

February 4, 2024

Merck & Co bolsters neurogenerative portfolio with Caraway acquisition

Share this article MSD will acquire Caraway in a deal worth up to $610m, including upfront and milestone-based payments. Image Credit: JHVEPhoto / Shutterstock. MSD

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.